Zacharenia Saridaki

Prognostic and predictive value of common mutations for treatment response and survival in patients with metastatic colorectal cancer

John Souglakos, Juliet Philips, R Wang et al. · British Journal of Cancer · 2009 · 320 citations · Full text

Medicine, Genetics, Oncology +17

Circulating tumor cells with a putative stem cell phenotype in peripheral blood of patients with breast cancer

Panayiotis A. Theodoropoulos, Hara Polioudaki, Sofia Agelaki et al. · Cancer Letters · 2009 · 286 citations

Medicine, Cell Biology, Oncology +17

Prognosis of stage II and III colon cancer treated with adjuvant 5-fluorouracil or FOLFIRI in relation to microsatellite status: results of the PETACC-3 trial

Dirk Klingbiel, Zacharenia Saridaki, A. Roth et al. · Annals of Oncology · 2014 · 237 citations · Full text

Medicine, Oncology, Chemotherapy +14

Impact of KRAS, BRAF, PIK3CA Mutations, PTEN, AREG, EREG Expression and Skin Rash in ≥2nd Line Cetuximab-Based Therapy of Colorectal Cancer Patients

Zacharenia Saridaki, Maria Tzardi, Chara Papadaki et al. · PLoS ONE · 2011 · 125 citations · Full text

Medicine, Oncology, Pharmacology +17

BRAF mutations, microsatellite instability status and cyclin D1 expression predict metastatic colorectal patients’ outcome

Zacharenia Saridaki, D. Papadatos-Pastos, Maria Tzardi et al. · British Journal of Cancer · 2010 · 118 citations · Full text

Medicine, Oncology, Pathology +17